Akre Capital
Streaks
6 names have been in this book every quarter on record (53). Nothing in this book is new this quarter.
Over time
Filings
- Q2 2026 filed Aug 14, 26 $5.1B · 19 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited
- Q1 2026 filed May 14, 26 $6.1B · 19 positions · 3 new · 2 exited full · Concentrated 3 new · 2 exited
- Q4 2025 filed Feb 13, 26 $9.1B · 18 positions · 0 new · 1 exited full · Very concentrated 0 new · 1 exited
- Q3 2025 filed Nov 13, 25 $10.0B · 19 positions · 0 new · 0 exited full · Very concentrated 0 new · 0 exited
- Q2 2025 filed Aug 13, 25 $10.2B · 19 positions · 2 new · 1 exited full · Very concentrated 2 new · 1 exited
- Q1 2025 filed May 13, 25 $10.4B · 18 positions · 0 new · 0 exited full · Very concentrated 0 new · 0 exited
- Q4 2024 filed Feb 13, 25 $11.6B · 18 positions · 0 new · 0 exited full · Very concentrated 0 new · 0 exited
- Q3 2024 filed Nov 13, 24 $12.0B · 18 positions · 0 new · 1 exited full · Very concentrated 0 new · 1 exited
- Q2 2024 filed Aug 13, 24 $11.4B · 19 positions · 1 new · 3 exited full · Very concentrated 1 new · 3 exited
- Q1 2024 filed May 23, 24 $24.2B · 21 positions · 3 new · 0 exited full · Very concentrated 3 new · 0 exited
- Q4 2023 filed Feb 9, 24 $11.9B · 18 positions · 1 new · 0 exited full · Very concentrated 1 new · 0 exited
- Q3 2023 filed Nov 13, 23 $10.9B · 17 positions · 0 new · 1 exited full · Very concentrated 0 new · 1 exited
- Q2 2023 filed Aug 11, 23 $12.0B · 18 positions · 0 new · 0 exited full · Very concentrated 0 new · 0 exited
- Q1 2023 filed May 12, 23 $11.4B · 18 positions · 0 new · 1 exited full · Very concentrated 0 new · 1 exited
- Q4 2022 filed Feb 13, 23 $11.1B · 19 positions · 2 new · 3 exited full · Very concentrated 2 new · 3 exited
- Q3 2022 filed Nov 14, 22 $11.3B · 20 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q2 2022 filed Aug 11, 22 $12.5B · 21 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q1 2022 filed May 13, 22 $14.4B · 21 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q4 2021 filed Feb 11, 22 $17.2B · 22 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q3 2021 filed Nov 12, 21 $16.2B · 23 positions · 0 new · 2 exited full · Concentrated 0 new · 2 exited
- Q2 2021 filed Aug 13, 21 $16.2B · 25 positions · 2 new · 1 exited full · Concentrated 2 new · 1 exited
- Q1 2021 filed Jul 9, 21 $14.7B · 24 positions · 1 new · 5 exited full · Concentrated 1 new · 5 exited
- Q4 2020 filed Feb 10, 21 $14.8B · 28 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited
- Q3 2020 filed Nov 13, 20 $14.2B · 28 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q2 2020 filed Aug 11, 20 $13.3B · 28 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited
- Q1 2020 filed May 11, 20 $10.3B · 28 positions · 4 new · 1 exited full · Concentrated 4 new · 1 exited
- Q4 2019 filed Feb 14, 20 $10.9B · 25 positions · 2 new · 2 exited full · Concentrated 2 new · 2 exited
- Q3 2019 filed Nov 13, 19 $10.1B · 25 positions · 5 new · 4 exited full · Concentrated 5 new · 4 exited
- Q2 2019 filed Aug 13, 19 $9.9B · 24 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q1 2019 filed May 13, 19 $9.5B · 25 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited
- Q4 2018 filed Feb 14, 19 $7.9B · 25 positions · 1 new · 0 exited full · Concentrated 1 new · 0 exited
- Q3 2018 filed Nov 14, 18 $8.6B · 24 positions · 1 new · 0 exited full · Concentrated 1 new · 0 exited
- Q2 2018 filed Aug 14, 18 $7.9B · 23 positions · 1 new · 2 exited full · Concentrated 1 new · 2 exited
- Q1 2018 filed May 15, 18 $7.6B · 24 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q4 2017 filed Feb 14, 18 $7.2B · 24 positions · 0 new · 2 exited full · Concentrated 0 new · 2 exited
- Q3 2017 filed Nov 14, 17 $6.8B · 26 positions · 0 new · 2 exited full · Concentrated 0 new · 2 exited
- Q2 2017 filed Aug 14, 17 $6.2B · 28 positions · 1 new · 4 exited full · Concentrated 1 new · 4 exited
- Q1 2017 filed May 15, 17 $6.1B · 31 positions · 0 new · 3 exited full · Concentrated 0 new · 3 exited
- Q4 2016 filed May 9, 17 $10.9B · 34 positions · 2 new · 1 exited full · Concentrated 2 new · 1 exited
- Q3 2016 filed Nov 14, 16 $5.2B · 33 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q2 2016 filed Aug 18, 17 $5.0B · 33 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q1 2016 filed May 13, 16 $4.7B · 34 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited
- Q4 2015 filed Feb 12, 16 $4.5B · 34 positions · 1 new · 2 exited full · Concentrated 1 new · 2 exited
- Q3 2015 filed Nov 12, 15 $4.3B · 35 positions · 1 new · 3 exited full · Concentrated 1 new · 3 exited
- Q2 2015 filed Aug 14, 15 $4.2B · 37 positions · 4 new · 2 exited full · Concentrated 4 new · 2 exited
- Q1 2015 filed Aug 29, 17 $3.9B · 35 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q4 2014 filed Feb 13, 15 $3.8B · 36 positions · 2 new · 5 exited full · Concentrated 2 new · 5 exited
- Q3 2014 filed Nov 13, 14 $3.5B · 39 positions · 1 new · 1 exited full · Concentrated 1 new · 1 exited
- Q2 2014 filed Aug 13, 14 $3.4B · 39 positions · 2 new · 5 exited full · Concentrated 2 new · 5 exited
- Q1 2014 filed May 13, 14 $3.1B · 42 positions · 3 new · 0 exited full · Concentrated 3 new · 0 exited
- Q4 2013 filed Feb 11, 14 $2.7B · 39 positions · 5 new · 1 exited full · Concentrated 5 new · 1 exited
- Q3 2013 filed Nov 13, 13 $2.3B · 35 positions · 2 new · 4 exited full · Concentrated 2 new · 4 exited
- Q2 2013 filed Aug 13, 13 $2.2B · 37 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited





